BenevolentAI
internal pipeline continued progress progress in several programmes have progressed through key stage gates candidate nominated enabling studies to begin als asset transitioned through to candidate seeking oncology programmes transitioned into lead new portfolio entrant for disease | BenevolentAI
Company
Deck Type
Deck date
September 2022
Slide
62 of 74
Similar slides by BenevolentAI
Results
March 2023
Investor Conference
January 2023
Investor Conference
January 2023
Investor Conference
November 2022
Related slides by other companies
Investor Presentation
May 2023
Results
November 2023
Results
November 2023
Investor Presentation
November 2023
Other recent decks by BenevolentAI
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io